New catheter for ventricular tachycardia
Part of Heart & circulation clinical trials.
This trial tests a new catheter system (Sphere-9 and Affera) to treat a fast, dangerous heartbeat called ventricular tachycardia (VT) in people with heart scarring. It aims to see if this system is safe and effective at stopping VT, especially if past treatments haven't worked.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of heart disease with scarring, either from a prior heart attack or other cause.
- You've had a fast, regular heartbeat (ventricular tachycardia) that lasted more than 30 seconds or needed a defibrillator to stop, within the last 6 months.
- You've tried medication or had your defibrillator treat this fast heartbeat, but it returned.
- You have a defibrillator or special pacemaker that's been in place for at least 3 months.
- You are between 18 and 85 years old.
- You are willing to follow the study schedule and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to find the exact spot in the heart that causes rapid heartbeats, so doctors can treat it more precisely with a procedure called catheter ablation.
This trial tests a new way of mapping the heart's electrical activity during a procedure called catheter ablation, which aims to treat a fast heart rhythm problem called ventricular tachycardia (VT). The hope is that this personalised approach will make the procedure more effective in stopping these abnormal rhythms.
This trial studies a non-invasive treatment using focused radiation to target the heart tissue causing dangerous heart rhythms. It may be an option for people who have already had a catheter ablation but still get episodes of ventricular tachycardia.
This trial tests a new catheter-based procedure to treat life-threatening irregular heartbeats (ventricular tachycardia) that keep coming back despite medication. If you've had a heart attack and your implanted defibrillator hasn't fully controlled these arrhythmias, this procedure might help prevent future episodes.
This trial tests a new treatment that uses short bursts of energy to target and destroy the heart tissue causing a fast, potentially serious heart rhythm problem (ventricular tachycardia). It's designed for people who already have an ICD and haven't gotten enough help from medications.
This trial is testing a new approach to treating a fast, dangerous heart rhythm (ventricular tachycardia) that comes from scar tissue in people with ischemic cardiomyopathy. The goal is to use a special mapping technique to guide the ablation (a procedure that destroys the tiny area causing the problem) to stop the arrhythmia.
Hear when a new Ventricular Tachycardia (VT) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.